Literature DB >> 12711728

Lower respiratory infections in nursing home residents with dementia: a tale of two countries.

David R Mehr1, Jenny T van der Steen, Robin L Kruse, Marcel E Ooms, Marilyn Rantz, Miel W Ribbe.   

Abstract

PURPOSE: A focus on palliative care for residents with dementia is much more common in Dutch nursing homes than in the United States. We compared treatment and mortality in U.S. and Dutch nursing home residents with lower respiratory infections (LRI), which are often the immediate cause of death in dementia. DESIGN AND METHODS: We studied two prospective cohorts--a study of pneumonia (n = 706) conducted in 61 psychogeriatric nursing homes throughout the Netherlands and 701 subjects with likely dementia from a study of LRIs in 36 nursing homes in Missouri.
RESULTS: Nursing home residents with dementia were more often treated without antibiotics in the Netherlands (23%) than in Missouri (15%). Indicators of severe illness operate in opposite directions: more severe illness is associated with antibiotic treatment in the United States, but with palliative treatment without antibiotics in the Netherlands. IMPLICATIONS: Our findings are consistent with others in indicating problems with transition to palliative care for U.S. nursing home residents with dementia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12711728     DOI: 10.1093/geront/43.suppl_2.85

Source DB:  PubMed          Journal:  Gerontologist        ISSN: 0016-9013


  8 in total

1.  Medical staff involvement in nursing homes: development of a conceptual model and research agenda.

Authors:  Renée Shield; Marsha Rosenthal; Terrie Wetle; Denise Tyler; Melissa Clark; Orna Intrator
Journal:  J Appl Gerontol       Date:  2012-11-28

Review 2.  Antibiotic use and associated factors in patients with dementia: a systematic review.

Authors:  Tessa van der Maaden; Simone A Hendriks; Henrica C W de Vet; Menno T Zomerhuis; Martin Smalbrugge; Elise P Jansma; Raymond T C M Koopmans; Cees M P M Hertogh; Jenny T van der Steen
Journal:  Drugs Aging       Date:  2015-01       Impact factor: 3.923

3.  A cross-cultural study of physician treatment decisions for demented nursing home patients who develop pneumonia.

Authors:  Margaret R Helton; Jenny T van der Steen; Timothy P Daaleman; George R Gamble; Miel W Ribbe
Journal:  Ann Fam Med       Date:  2006 May-Jun       Impact factor: 5.166

4.  Survival and comfort after treatment of pneumonia in advanced dementia.

Authors:  Jane L Givens; Richard N Jones; Michele L Shaffer; Dan K Kiely; Susan L Mitchell
Journal:  Arch Intern Med       Date:  2010-07-12

Review 5.  Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying?

Authors:  Carole Parsons; Carmel M Hughes; A Peter Passmore; Kate L Lapane
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

6.  Antibiotic treatment and survival of nursing home patients with lower respiratory tract infection: a cross-national analysis.

Authors:  Robin L Kruse; David R Mehr; Jenny T van der Steen; Marcel E Ooms; Richard W Madsen; Ashley K Sherman; Ralph B D'Agostino; Gerrit van der Wal; Miel W Ribbe
Journal:  Ann Fam Med       Date:  2005 Sep-Oct       Impact factor: 5.166

7.  Advanced dementia: state of the art and priorities for the next decade.

Authors:  Susan L Mitchell; Betty S Black; Mary Ersek; Laura C Hanson; Susan C Miller; Greg A Sachs; Joan M Teno; R Sean Morrison
Journal:  Ann Intern Med       Date:  2012-01-03       Impact factor: 25.391

8.  The trial to reduce antimicrobial use in nursing home residents with Alzheimer's disease and other dementias: study protocol for a cluster randomized controlled trial.

Authors:  Andrea J Loizeau; Erika M C D'Agata; Michele L Shaffer; Laura C Hanson; Ruth A Anderson; Timothy Tsai; Daniel A Habtemariam; Elaine H Bergman; Ruth P Carroll; Simon M Cohen; Erin M E Scott; Erin Stevens; Jeremy D Whyman; Elizabeth H Bennert; Susan L Mitchell
Journal:  Trials       Date:  2019-10-15       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.